DIAGNOSTIC CYTOGENETICS
NPI 1104899376
Clinical Medical Laboratory in Seattle, WA

NPI Status: Active since February 08, 2006

Contact Information

2360 W COMMODORE WAY STE 201
SEATTLE, WA
ZIP 98199
Phone: (206) 328-2026
Fax: (206) 325-2975

Get Directions Write a Review

  • Organization
  • Clinical Medical Laboratory
  • Accepts Insurance
  • CLIA Number: 50D0721329
  • CLIA Cert. Type: Independent
  • CLIA Exp. Date: 04-04-2028

About DIAGNOSTIC CYTOGENETICS

This page provides the complete NPI Profile along with additional information for Diagnostic Cytogenetics, a provider established in Seattle, Washington operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1104899376 assigned on February 2006. The practitioner's primary taxonomy code is 291U00000X with license number MTS-0439 (WA). The provider is registered as an organization and their NPI record was last updated 3 years ago. The authorized official of this NPI record is Kyndra M Mcdougal (Chief Regulatory Officer)

NPI
1104899376
Provider Name
DIAGNOSTIC CYTOGENETICS
Entity Type
Organization
Location Address
2360 W COMMODORE WAY STE 201 SEATTLE, WA 98199
Location Phone
(206) 328-2026
Location Fax
(206) 325-2975
Mailing Address
2360 W COMMODORE WAY STE 201 SEATTLE, WA 98199
Mailing Phone
(206) 328-2026
Mailing Fax
(206) 325-2975
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
02-08-2006
Last Update Date
02-16-2023
Code Navigator

Establishments like Diagnostic Cytogenetics are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.

Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinical Medical Laboratory

Taxonomy Code
291U00000X
Type
Laboratories
License No.
MTS-0439
License State
WA
Taxonomy Description
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

Insurance Plans Accepted

According to publicly available information the provider might be accepting the following health plans from these health insurance companies:

  • Navigator Bronze 7000 Exchange - PPO
  • Navigator Bronze 9200 - PPO
  • Navigator Bronze HSA 8050 - PPO
  • Navigator Gold 1500 - PPO
  • Navigator Gold 1500 Exchange - PPO
  • Navigator Gold 500 Exchange - PPO
  • Navigator Silver 3500 Exchange - PPO
  • Navigator Silver 4000 Exchange - PPO
  • Navigator Silver 5000 - PPO
  • Navigator Silver HSA 3500 - PPO
  • Navigator Standard Expanded Bronze - PPO
  • Navigator Standard Gold - PPO
  • Navigator Standard Silver - PPO
  • PacificSource Oregon Standard Bronze Plan NAV - PPO
  • PacificSource Oregon Standard Gold Plan NAV - PPO
  • PacificSource Oregon Standard Silver Plan NAV - PPO
  • Premera Blue Cross Alaska One Gold - PPO
  • Premera Blue Cross Preferred Bronze 5800 HSA - PPO
  • Premera Blue Cross Preferred Bronze 6350 - PPO
  • Premera Blue Cross Preferred Gold 1500 - PPO
  • Premera Blue Cross Preferred Silver 4500 - PPO
  • Premera Blue Cross Standard Bronze II - PPO
  • Premera Blue Cross Standard Gold - PPO
  • Premera Blue Cross Standard Silver - PPO

Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.

Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.

*Please verify directly with this provider to make sure your insurance plan is currently accepted.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

KYNDRA M MCDOUGAL

Authorized Official Title
CHIEF REGULATORY OFFICER
Authorized Official Phone
(888) 618-9107

Additional Identifiers

The NPI Enumerator encourages providers to submit additional identifiers with their NPI application although the submission of this information is optional. The additional identifier(s) section includes other numbers or codes currently or formerly used as an identifier for the provider by other public healthcare entities. The identifiers may include UPIN, NSC, OSCAR, DEA, Medicaid State or PIN identification numbers.

Identifier Type / Code Identifier State Identifier Issuer
7271406MEDICAID (05)WA 

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Analysis of urine, except immunoassays

Analysis of urine, often termed a urinalysis, is a routine test that checks for different substances present in the urine. It's a simple, non-invasive procedure that can help diagnose and monitor various health conditions, including kidney disease and diabetes.

This service was performed 648 times for 380 patients

Cell examination of specimen, selective cellular enhancement technique

Cell examination of a specimen using selective cellular enhancement technique is a lab process that improves the visibility of certain cells in a sample. It helps in identifying abnormalities or diseases. The process is non-invasive, safe, and aids in accurate diagnosis.

This service was performed 32 times for 30 patients

Chromosome analysis for genetic defects, additional cells counted, each study

Chromosome analysis is a study that examines your body's chromosomes to identify any genetic defects. In some cases, additional cells may be counted to ensure accuracy. This can provide valuable information about potential health risks and inform treatment decisions.

This service was performed 27 times for 27 patients

Chromosome analysis for genetic defects, additional karyotypes, each study

Chromosome analysis is a test that examines the number and structure of a person's chromosomes. This is done to identify any genetic defects. Additional karyotypes, each study, are further tests that look at the arrangement of these chromosomes. This can help in detecting genetic disorders.

This service was performed 125 times for 123 patients

Chromosome analysis for genetic defects, analyze 20-25 cells

Chromosome analysis is a test that evaluates your cells to check for genetic defects. In this procedure, 20-25 cells are examined under a microscope to identify any abnormalities. This information can help in diagnosing certain genetic conditions and guide treatment plans.

This service was performed 104 times for 104 patients

Chromosome analysis for genetic defects, count 5 cells

Chromosome analysis is a test that examines the number and structure of your cells. It helps identify any genetic defects that might cause health issues. In this procedure, 5 cells are analyzed to ensure accuracy. The results may provide crucial information for your health management.

This service was performed 18 times for 18 patients

Detection of mycoplasma genitalium by dna or rna probe

This procedure involves the use of special probes to identify the presence of a specific bacteria, Mycoplasma Genitalium, in your body. These probes detect the bacteria's unique DNA or RNA, helping to confirm if you have an infection.

This service was performed 536 times for 375 patients

Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique

A detection test by nucleic acid for chlamydia trachomatis, amplified probe technique, is a test that identifies the presence of a specific bacteria in the body. This bacteria can cause various health issues. The technique amplifies the sample to improve accuracy.

This service was performed 107 times for 95 patients

Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique

A detection test by nucleic acid for cytomegalovirus (CMV) using an amplified probe technique is a lab procedure. It identifies the presence of CMV, a common virus, in your body. This technique amplifies the virus's genetic material, making it easier to detect.

This service was performed 157 times for 141 patients

Detection test by nucleic acid for herpes simplex virus, amplified probe technique

This test uses an amplified probe technique to identify the presence of the herpes simplex virus in your body. It works by detecting the virus's genetic material, or nucleic acid. The test is accurate, reliable, and can help in early detection and treatment.

This service was performed 210 times for 94 patients

Detection test by nucleic acid for human papillomavirus (hpv), high-risk types

This test detects high-risk types of HPV, a common virus. It's done by analyzing a small sample of cells for the presence of HPV DNA. The aim is to identify any high-risk types early, as they may increase the risk of certain health issues.

This service was performed 20 times for 20 patients

Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique

This is a lab test that checks for the presence of a specific bacteria called Neisseria gonorrhoeae in your body. It uses a technique called amplified probe, which makes many copies of the bacteria's genetic material (nucleic acid) to help detect it more easily.

This service was performed 107 times for 95 patients

Detection test by nucleic acid for organism, amplified probe technique

A nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.

This service was performed 714 times for 63 patients

Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique

A detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.

This service was performed 588 times for 421 patients

Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique

A detection test by nucleic acid for MRSA bacteria uses an amplified probe technique. It's a lab procedure that identifies the presence of MRSA, a type of bacteria resistant to many antibiotics. This test helps in deciding the best treatment.

This service was performed 157 times for 128 patients

Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique

A detection test by nucleic acid for Group B Strep uses an amplified probe technique. This test identifies the presence of Group B Strep bacteria in the body. It involves collecting a sample, usually a swab, which is then examined in a lab for the bacteria's genetic material.

This service was performed 586 times for 419 patients

Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique

This is a test to identify a common microscopic organism that can cause discomfort. The technique involves using a special probe to amplify the organism's genetic material, making it easier to detect. It's a simple, safe, and accurate procedure.

This service was performed 123 times for 109 patients

Detection test for gardnerella vaginalis (bacteria), amplified probe technique

This test helps find a specific type of bacteria in the body. It uses a method called the amplified probe technique, which amplifies the bacteria's genetic material, making it easier to detect. It's a standard, pain-free procedure.

This service was performed 323 times for 229 patients

Identification of organisms by genetic analysis, amplified probe technique

This procedure involves identifying organisms like bacteria or viruses in your body. It's done by amplifying a small part of their genetic material, making it easier to detect. This technique helps in accurate diagnosis and appropriate treatment.

This service was performed 1,884 times for 128 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within

This is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.

This service was performed 4,117 times for 2,374 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r

This is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.

This service was performed 4,121 times for 2,377 patients

Interpretation and report of genetic testing

Interpretation and report of genetic testing involves analyzing your DNA to look for changes that could indicate a risk for certain health conditions. The results are then compiled into a report, which provides insights about your genetic health.

This service was performed 238 times for 229 patients

Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure

Microscopic genetic analysis of tissue is a detailed lab process that examines your cells' genetic material. If more than one stain procedure is needed, it's termed an 'additional multiplex stain procedure'. This helps to highlight different components within your cells, aiding in accurate diagnosis and treatment planning.

This service was performed 905 times for 216 patients

Pap test

A Pap test is a routine exam that checks for changes in cells that could signal a health concern. During this test, a small sample of cells is gently collected from the lower region of the body. The sample is then examined under a microscope to ensure everything looks normal.

This service was performed 49 times for 49 patients

Pap test, automated thin layer preparation; automated system and manual rescreening

A Pap test is a screening tool that helps detect unusual cells. The automated thin layer preparation involves placing your cell sample in a thin layer on a slide. An automated system then scans the slide, and experts manually review any areas flagged by the system. This method enhances the accuracy of the results.

This service was performed 46 times for 46 patients

Tissue culture for tumor disorders of bone marrow and blood cells

Tissue culture for tumor disorders of bone marrow and blood cells is a lab process where your cells are grown in a controlled environment. The aim is to detect and study abnormal cells, such as cancer, in your bone marrow or blood. This helps in planning effective treatment.

This service was performed 204 times for 144 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
50D0721329
Facility Type
Independent
Certificate Effective Date
August 30, 1996
Certificate Expiration Date
April 04, 2028
Laboratory Director
DR. MICHAEL H. KALNOSKI
Certificate Type
Certificate of Accreditation
Certificate Type Description
This is a CLIA certificate is issued to Diagnostic Cytogenetics on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.

Reviews for DIAGNOSTIC CYTOGENETICS

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI Validation Check Digit Calculation


The following table explains the step by step NPI number validation process using the ISO standard Luhn algorithm.

Start with the original NPI number, the last digit is the check digit and is not used in the calculation.
1104899376
Step 1: Double the value of the alternate digits, beginning with the rightmost digit.
210416918314
Step 2: Add all the doubled and unaffected individual digits from step 1 plus the constant number 24.
2 + 1 + 0 + 4 + 1 + 6 + 9 + 1 + 8 + 3 + 1 + 4 + 24 = 64
Step 3: Subtract the total obtained in step 2 from the next higher number ending in zero, the result is the check digit.
70 - 64 = 66

The NPI number 1104899376 is valid because the calculated check digit 6 using the Luhn validation algorithm matches the last digit of the original NPI number.

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1104899376, enumerated as an "organization" on February 08, 2006.

The provider is located at 2360 W COMMODORE WAY STE 201 SEATTLE, WA 98199 and the phone number is (206) 328-2026.

Clinical Medical Laboratory with taxonomy code 291U00000X.

The provider might be accepting Accepts: PacificSource Health Plans, Premera Blue Cross. Please consult your insurance carrier or call the provider to verify.